Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biovaxys Technology Corp (BVAXF)

Biovaxys Technology Corp (BVAXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
BioVaxys to Participate in the US Government Biomedical Advanced Research and Development Authority (BARDA) Rapid Response Partnership Vehicle (RRPV) Vaccine Development Consortium

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that it has been invited to and...

BVAXF : 0.0501 (+1.42%)
BIOV.CN : 0.0700 (unch)
BioVaxys' DPX Exhibits Superior Immune System Activation Compared to Aqueous and Emulsion-Based Antigen Delivery Systems

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") highlights studies showing that its novel immune...

BVAXF : 0.0501 (+1.42%)
BIOV.CN : 0.0700 (unch)
BioVaxys to Present at the Emerging Growth Conference on October 30th, 2024

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") a clinical-stage company developing a portfolio of...

BVAXF : 0.0501 (+1.42%)
BIOV.CN : 0.0700 (unch)
BioVaxys Engages Dr. Rajkannan Rajagopalan as Vaccine Formulations Advisor

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is pleased to announce that it has engaged Rajkannan Rajagopalan, PhD,...

BVAXF : 0.0501 (+1.42%)
BIOV.CN : 0.0700 (unch)
Analysts Predict Strong Growth for Cancer Vaccine Market: Key Biotech Stocks to Consider

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – Back in 2022, Nature published...

BIOV.CN : 0.0700 (unch)
BVAXF : 0.0501 (+1.42%)
BNTX : 101.67 (+1.96%)
CVAC : 2.62 (+3.15%)
VXRT : 0.6128 (+5.64%)
IBRX : 4.91 (+9.35%)
BioVaxys to Present New Data on its DPX Immune Educating Platform at Personalized Cancer Vaccine Summit

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the Company") is pleased to announce that it has been invited to...

BIOV.CN : 0.0700 (unch)
BVAXF : 0.0501 (+1.42%)
The Future of Medicine: Drug Delivery Innovations Leading a $700 Billion Market

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – In the field of medicine, many...

LEXX : 2.04 (+1.49%)
BIOV.CN : 0.0700 (unch)
BVAXF : 0.0501 (+1.42%)
TFFP : 0.3587 (-4.63%)
DNTH : 23.57 (+0.90%)
AQST : 4.61 (+3.83%)
BioVaxys DPX-Based Vaccines Exhibit Robust Efficacy Across Multiple Infectious Diseases

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") highlights the potential of its novel lipid-in-oil...

BIOV.CN : 0.0700 (unch)
BVAXF : 0.0501 (+1.42%)
Sustainable Agriculture: The Growing Need for Biotech Innovations in the World's Food Supplies

/CNW/ -- USA News Group – How we take care of the planet, and the food we eat is rapidly shifting. Back in May, the World Economic Forum addressed how...

BIOV.CN : 0.0700 (unch)
BVAXF : 0.0501 (+1.42%)
ZTS : 176.18 (+0.59%)
CTVA : 56.69 (+2.68%)
BG : 91.32 (+1.56%)
BRFS : 4.14 (-3.94%)
Innovative Agritech Solutions Powering the Future of Sustainable Agriculture

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – How we take care of the planet,...

BIOV.CN : 0.0700 (unch)
BVAXF : 0.0501 (+1.42%)
ZTS : 176.18 (+0.59%)
CTVA : 56.69 (+2.68%)
BG : 91.32 (+1.56%)
BRFS : 4.14 (-3.94%)

Barchart Exclusives

Is This Fintech Stock a Buy Before Its Q1 Earnings Release?
Intuit is a high-quality fintech stock with growing potential. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar